주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-03-28 16:29 (Thurs)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Policy
목록
(
총 :
642 )
기사목록 보기 형태
제목형
요약형
포토형
Insurer to cut coverage for brain, and cerebrovascular MRIs from October
Kwak Sung-sun
2023.07.18 14:35
Malaria cases in Korea surge 2.4 times in H1
Lee Han-soo
2023.07.17 13:08
Pfizer's oral Covid-19 treatment got full approval in Korea. What about Korean oral drugs?
Lee Han-soo
2023.07.14 17:23
Korea pushes to internationalize industrial standards for 166 medical devices
Park Gi-taek
2023.07.14 15:45
Korea maintains aspartame intake level despite WHO's classification as possible carcinogen
Lee Han-soo
2023.07.14 14:31
‘Physician-assisted suicide feared to fall into easier option than palliative care’
Kim Ju-yeon
2023.07.13 14:20
Health ministry urges cancellation of e-cigarette show, citing safety concerns
Lee Han-soo
2023.07.12 14:52
Minister urges health workers ‘not to join umbrella union’s political strike’
Kwak Sung-sun
2023.07.11 11:50
159 overseas medical schools recognized for Korean medical licensing eligibility
Kwak Sung-sun
2023.07.10 16:30
National infectious diseases crisis response head appointed as new NHIS chief
Lee Han-soo
2023.07.10 11:06
Korea to create ‘Global Bio Campus’ to train foreign manufacturing workers
Kwak Sung-sun
2023.07.07 15:57
Gangnam Unni CEO sentenced to prison for 'profiting from patient referrals'
Kim Eun-young
2023.07.06 14:47
처음
이전
이전
이전
21
22
23
24
25
26
27
28
29
30
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기